Skip to content
Search the site

Can Adults in Their 40s Get the Arexvy RSV Vaccine? Eligibility Explained

REGOLITH English ·

Video description

South Korea expanded the approved indications for the RSV vaccine Arexvy in July 2026. Learn which high-risk adults aged 18–49 may qualify, how eligibility differs for adults in their 50s and those aged 60 and older, which RSV vaccines are available in South Korea, out-of-pocket costs, and precautions before vaccination. 00:00 Adults Under 50 May Qualify 00:41 Why RSV Risk Matters 01:32 Which Conditions May Qualify? 02:29 A Diagnosis Does Not Guarantee Eligibility 03:22 How Eligibility Changes With Age 04:12 Which RSV Vaccines Are Available in South Korea? 05:07 Medical Checks Before Vaccination 06:00 Evidence, Costs, and Questions for Your Clinic This video includes AI-generated explanatory images and synthetic narration.

Watch the original on YouTube

More videos

Visitor statistics


Copyright © regolith.kr. All rights reserved. IP Geolocation by DB-IP